Management ChangeApr 27, 2026, 06:08 AM
SYRA Appoints Gregory Alexander CEO; Amends 10-K for Governance
AI Summary
Syra Health Corp filed an Amendment No. 1 to its 2025 Annual Report on Form 10-K to include previously omitted information regarding corporate governance, executive compensation, and related party transactions. The filing details significant management changes, including the appointment of Gregory R. Alexander as CEO effective January 5, 2026, following the termination of former CEO Deepika Vuppalanchi for cause and the passing of former President Sandeep Allam. The amendment also outlines compensation for the new CEO and other executives, director compensation, and various related party transactions.
Key Highlights
- Gregory R. Alexander appointed CEO effective January 5, 2026.
- Former CEO Deepika Vuppalanchi terminated for cause on June 13, 2025.
- Former President Sandeep Allam passed away on January 15, 2025.
- New CEO Alexander's annual base salary is $251,000 with a 30% target bonus.
- New CEO Alexander granted 110,537 restricted stock units and 257,920 stock options.
- Priya Prasad's 2025 compensation was $272,964, up from $171,291 in 2024.
- Related party IT services expenses increased to $340,757 in 2025.
- Company owed $72,000 in director fees as of December 31, 2025.
Price Impact
More from SYRA